Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenalytix Plc Regulatory News (RENX)

Share Price Information for Renalytix Plc (RENX)

Share Price is delayed by 15 minutes
Get Live Data
1.80    0.00 (0.00%)
Bid:
1.60
Ask:
2.00
Spread: 0.40 (25.00%)
Market Cap: £7.87m
RENX Live PriceLast checked at - London Stock Exchange

Intraday Renalytix Plc Share Chart

Director/PDMR Shareholding

20 Dec 2018 17:20

RNS Number : 1932L
Renalytix AI PLC
20 December 2018
 

Renalytix AI plc

("RenalytixAI" or the "Company") 

 

Director/ PDMR Shareholding

 

The Company was informed that today, Christopher Mills, a non-executive director, completed the purchase of 3,168 ordinary shares of 0.25 pence each ("Ordinary Shares") in the Company at a price of 112 pence per share.

 

Following this purchase, Mr Mills is interested in 9,199,568 Ordinary Shares representing 17.09% of the total voting rights in the Company.

 

Enquiries:

 

Renalytix AI plc

www.renalytixai.com

James McCullough, CEO

Via Walbrook PR or Tel: +1 646 397 3970

 

 

N+1 Singer (Nominated Adviser & Broker)

Tel: 020 7496 3000

Aubrey Powell / James White / George Tzimas (Corporate Finance)

 

Tom Salvesen / Mia Gardner (Corporate Broking)

 

 

 

Walbrook PR Limited

Tel: 020 7933 8780 or renalytix@walbrookpr.com

Paul McManus / Lianne Cawthorne

Mob: 07980 541 893 / 07584 391 303

     

 

 

  

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 

Harwood Capital LLP (Harwood) as investment manager to North Atlantic Smaller Companies Investment Trust plc and Oryx

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Christopher Mills, non-exec director of the issuer and director of NASCIT and Oryx International Growth Fund Ltd

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Renalytix AI plc

b)

 

LEI

 

 

213800NTOH3FK3WER551

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 0.25 pence each

 

 

 

Identification code

GB00BYWL4Y04

 

 

 

b)

 

Nature of the transaction

 

 

Share purchase

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

Price(s)

Volume(s)

 

 

 

112.00 pence

3,168

 

 

 

 

 

 

d)

 

Aggregated information

 

 

 

- Aggregated volume

3,168

 

 

- Price

£3,548.16

 

 

e)

 

Date of the transaction

 

20 December 2018

f)

 

Place of the transaction

 

London Stock Exchange

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFKKDDOBDDFBB
Date   Source Headline
29th May 20264:24 pmRNSHolding(s) in Company
27th May 202611:20 amRNSHolding(s) in Company
18th May 20263:52 pmRNSHolding(s) in Company
5th May 20263:26 pmRNSHolding(s) in Company
5th May 20269:39 amRNSHolding(s) in Company
1st May 20269:23 amRNSHolding(s) in Company
29th Apr 20264:17 pmRNSHolding(s) in Company
23rd Apr 202611:46 amRNSHolding(s) in Company
23rd Apr 202611:42 amRNSHolding(s) in Company
22nd Apr 20267:00 amRNSKey milestones achieved for kidneyintelX.dkd
16th Apr 20266:04 pmRNSHolding(s) in Company
16th Apr 20269:16 amRNSHolding(s) in Company
9th Apr 20264:29 pmRNSHolding(s) in Company
7th Apr 20265:25 pmRNSHolding(s) in Company
7th Apr 20265:24 pmRNSHolding(s) in Company
30th Mar 20263:41 pmRNSHolding(s) in Company
26th Mar 20267:00 amRNSHalf-year Report
18th Mar 20261:55 pmRNSHolding(s) in Company
17th Mar 202611:22 amRNSHolding(s) in Company
13th Mar 20262:02 pmRNSHolding(s) in Company
13th Mar 20262:02 pmRNSHolding(s) in Company
27th Feb 20267:00 amRNSHolding(s) in Company
13th Feb 20262:30 pmRNSFurther CEO Share Purchase
13th Feb 20267:00 amRNSDirector/PDMR Shareholding
12th Feb 20267:01 amRNSDirector/PDMR Share Purchase
12th Feb 20267:00 amRNSCEO Share Purchase
11th Feb 20267:00 amRNSH1 Trading update
21st Jan 20263:20 pmRNSHolding(s) in Company
15th Jan 20264:51 pmRNSHolding(s) in Company
12th Jan 20267:00 amRNSThree kidneyintelX.dkd Clinical Integrations
9th Jan 20262:43 pmRNSHolding(s) in Company
6th Jan 20264:28 pmRNSHolding(s) in Company
24th Dec 202512:56 pmRNSHolding(s) in Company
24th Dec 202512:56 pmRNSHolding(s) in Company
23rd Dec 20254:13 pmRNSHolding(s) in Company
23rd Dec 20254:13 pmRNSHolding(s) in Company
19th Dec 202512:18 pmRNSHolding(s) in Company
19th Dec 202512:18 pmRNSHolding(s) in Company
17th Dec 20251:42 pmRNSHolding(s) in Company
16th Dec 20251:51 pmRNSHolding(s) in Company
9th Dec 202510:57 amRNSResult of AGM
9th Dec 20257:00 amRNSAGM Statement
27th Nov 20252:39 pmRNSHolding(s) in Company
25th Nov 20253:44 pmRNSHolding(s) in Company
25th Nov 20257:00 amRNSPlan to Implement ADS Ratio Change
12th Nov 20257:00 amRNSPivotal kidneyintelX.dkd data published
5th Nov 20254:02 pmRNSHolding(s) in Company
4th Nov 20256:05 pmRNSPublication of Annual Report & Notice of AGM
3rd Nov 202512:05 pmRNSHolding(s) in Company
3rd Nov 20257:00 amRNSAudited Full Year Fiscal 2025 Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.